Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other neoplasm 1

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 6Rectal Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Colonic Neoplasms 5Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Follicular 4Immunoblastic Lymphadenopathy 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Sezary Syndrome 3Pancreatic Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Mantle-Cell 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Esophageal Neoplasms 3Burkitt Lymphoma 3Adenocarcinoma Of Esophagus 3Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Cisplatin 76Cetuximab 60pembrolizumab 56Radiotherapy, Intensity-Modulated 37Radiotherapy 33Carboplatin 31Docetaxel 30Fluorouracil 27Nivolumab 26Paclitaxel 20Platinum 10Albumin-Bound Paclitaxel 9Surgical Procedures, Operative 8Radiosurgery 8Radiation 8Erlotinib Hydrochloride 8durvalumab 7Bevacizumab 71,2-diaminocyclohexaneplatinum II citrate 7epacadostat 6Biopsy 6Radiotherapy, Conformal 5Ipilimumab 5Immunoglobulin G 5Gemcitabine 5Capecitabine 5130-nm albumin-bound paclitaxel 5utomilumab 4tremelimumab 4palbociclib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Squamous Cell Carcinoma of Head and Neck × Immunohistochemistry × Clear all
NCT00720304 2024-08-22

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Case Comprehensive Cancer Center

Phase 2 Completed
43 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡